P
Paul I. Terasaki
Researcher at University of California, Los Angeles
Publications - 644
Citations - 44657
Paul I. Terasaki is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Transplantation & Human leukocyte antigen. The author has an hindex of 96, co-authored 644 publications receiving 43274 citations. Previous affiliations of Paul I. Terasaki include Kyoto University & University of California.
Papers
More filters
Journal ArticleDOI
Nomenclature for factors of the HLA system, 2010.
Steven G.E. Marsh,E. D. Albert,Walter F. Bodmer,Ronald E. Bontrop,Bo Dupont,Henry A. Erlich,Marcelo Fernandez-Vina,Daniel E. Geraghty,Rhonda Holdsworth,Carolyn Katovich Hurley,M. Lau,Keun-Seok Lee,Bernard Mach,Martin Maiers,Wolfgang R. Mayr,Carlheinz Müller,Peter Parham,Effie W. Petersdorf,Takehiko Sasazuki,Jack L. Strominger,A. Svejgaard,Paul I. Terasaki,Jean-Marie Tiercy,John Trowsdale +23 more
TL;DR: This report documents the additions and revisions to the nomenclature of HLA specificities following the principles established in previous reports.
Journal ArticleDOI
Microdroplet Assay of Human Serum Cytotoxins
TL;DR: The method recorded here for assaying lymphocyte cytotoxins in a microscale was developed to circumvent difficulties in handling small quantities of serum and cells and in gaining a greater than ten-fold increase in sensitivity over present-day methods.
Journal ArticleDOI
Significance of the positive crossmatch test in kidney transplantation.
Ramon Patel,Paul I. Terasaki +1 more
TL;DR: Crossmatch tests of the prospective kidney-transplant donor's lymphocytes with the serum of thespective recipient in 225 transplants showed that eight of 195 with negative crossmatch tests for the prospective recipient were found to be positive.
Journal ArticleDOI
High Association of an HL-A Antigen, W27, with Ankylosing Spondylitis
TL;DR: The frequencies of 24 HL-A antigens were examined in patients with ankylosing spondylitis, 119 with rheumatoid arthritis, and 66 with gout, finding no significant deviation from control frequen...
Journal ArticleDOI
Effect of pravastatin on outcomes after cardiac transplantation.
Jon A. Kobashigawa,S. Katznelson,Hillel Laks,Jay A. Johnson,Lawrence A. Yeatman,X M Wang,D Chia,Paul I. Terasaki,A. Sabad,G. A. Cogert +9 more
TL;DR: After cardiac transplantation, pravastatin had beneficial effects on cholesterol levels, the incidence of rejection causing hemodynamic compromise, one-year survival, andThe incidence of coronary vasculopathy.